| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-28 | FY 2024
FILED 2024-12-29 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $282.3M | $315.9M | $355.2M |
| YoY Revenue Growth % | -10.6% | -11.1% | — |
| Gross Profit | $122.1M | $130.2M | — |
| Gross Margin % | 43.2% | 41.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$12.6M | -$52.4M | -$20.2M |
| Operating Margin % | -4.5% | -16.6% | -5.7% |
| Net Income (GAAP) | -$13.7M | -$55.3M | -$19.3M |
| EBITDA (Normalized) | -$12.3M | -$51.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.4M | $2.6M | $15.4M |
| Capital Expenditures (CapEx) | $350.0K | $1.3M | — |
| Free Cash Flow (FCF) | $1.0M | $1.3M | $15.4M |
| FCF Margin % | 0.4% | 0.4% | 4.3% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $2.7M | $4.5M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $3.0M | $13.4M | — |